Open access
Oct 2026
Epigenetic silencing of PDLIM4 promotes colorectal cancer by impairing BTF3 autophagic degradation and activating PI3K/Akt signalling
DNMT3A‐mediated silencing of PDLIM4 is an early epigenetic event that facilitates CRC progression and the potential of PDLIM4 methylation as a non‐invasive CRC biomarker is supported.
Jia-Xin Wang, Chuan-Guo Guo, L. Qi et al.
· Clinical and Translational M... · 0 citations